Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Treace Medical Concepts, Inc. (TMCI) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Treace Medical Concepts, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1630627.
Total stock buying since 2021: $9,709,738.
Total stock sales since 2021: $199,813,580.
Total stock option exercises since 2021: $493,207.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 50,000 | $398,450 | 83,437 | $76,507 |
| 2024 | 1,341,456 | $6,620,813 | 0 | $0 | 33,750 | $3,273 |
| 2023 | 0 | $0 | 2,307,703 | $58,629,823 | 81,250 | $51,425 |
| 2022 | 139,261 | $2,857,725 | 1,489,748 | $30,721,932 | 143,875 | $291,888 |
| 2021 | 13,600 | $231,200 | 6,389,206 | $110,063,375 | 333,641 | $70,114 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 0 | $0 | 33,437 | $24,007 |
| 2025-03 | 0 | $0 | 50,000 | $398,450 | 50,000 | $52,500 |
| 2024-09 | 50,000 | $265,650 | 0 | $0 | 33,750 | $3,273 |
| 2024-08 | 169,000 | $1,011,399 | 0 | $0 | 0 | $0 |
| 2024-06 | 45,000 | $264,600 | 0 | $0 | 0 | $0 |
| 2024-05 | 1,077,456 | $5,079,164 | 0 | $0 | 0 | $0 |
| 2023-06 | 0 | $0 | 1,090,821 | $28,917,664 | 0 | $0 |
| 2023-05 | 0 | $0 | 35,000 | $890,715 | 25,000 | $2,500 |
| 2023-04 | 0 | $0 | 173,964 | $4,511,766 | 0 | $0 |
| 2023-03 | 0 | $0 | 431,373 | $10,467,119 | 6,250 | $43,925 |
| 2023-02 | 0 | $0 | 171,658 | $3,742,781 | 25,000 | $2,500 |
| 2023-01 | 0 | $0 | 404,887 | $10,099,778 | 25,000 | $2,500 |
| 2022-12 | 0 | $0 | 162,906 | $3,802,473 | 5,625 | $67,578 |
| 2022-11 | 70,561 | $1,531,079 | 275,050 | $6,034,014 | 31,250 | $46,425 |
| 2022-10 | 0 | $0 | 227,077 | $5,300,952 | 0 | $0 |
| 2022-09 | 10,000 | $198,030 | 158,349 | $3,644,453 | 2,500 | $17,559 |
| 2022-08 | 50,000 | $984,106 | 264,364 | $5,056,673 | 2,500 | $17,570 |
| 2022-07 | 0 | $0 | 50,000 | $808,056 | 0 | $0 |
| 2022-06 | 0 | $0 | 51,000 | $700,144 | 1,000 | $7,028 |
| 2022-05 | 6,200 | $97,960 | 126,000 | $1,892,161 | 1,000 | $7,028 |
| 2022-03 | 2,500 | $46,550 | 25,002 | $520,588 | 25,000 | $26,250 |
| 2022-02 | 0 | $0 | 25,000 | $500,982 | 25,000 | $26,249 |
| 2022-01 | 0 | $0 | 125,000 | $2,461,436 | 50,000 | $76,201 |
| 2021-12 | 0 | $0 | 315,000 | $5,197,015 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-18 | Scanlan Sean F. (Chief Innovation Officer) | Option Ex | 33,437 | .72 | 24,007 |
| 2025-03-17 | Scanlan Sean F. (Chief Innovation Officer) | Sale | 50,000 | 7.97 | 398,450 |
| 2025-03-17 | Scanlan Sean F. (Chief Innovation Officer) | Option Ex | 50,000 | 1.05 | 52,500 |
| 2024-09-16 | Treace John T. (Chief Executive Officer) | Buy | 50,000 | 5.31 | 265,650 |
| 2024-09-12 | Scanlan Sean F. (Chief Innovation Officer) | Option Ex | 33,750 | .10 | 3,273 |
| 2024-08-15 | Treace James T | Buy | 84,000 | 5.96 | 501,060 |
| 2024-08-14 | Treace John T. (Chief Executive Officer) | Buy | 85,000 | 6.00 | 510,339 |
| 2024-06-11 | Treace John T. (Chief Executive Officer) | Buy | 45,000 | 5.88 | 264,600 |
| 2024-05-31 | Treace James T | Buy | 25,000 | 6.05 | 151,325 |
| 2024-05-28 | Treace James T | Buy | 50,000 | 5.07 | 253,500 |
| 2024-05-24 | Mott Richard W | Buy | 18,000 | 5.20 | 93,510 |
| 2024-05-22 | Mott Richard W | Buy | 12,100 | 4.99 | 60,427 |
| 2024-05-14 | Treace John T. (Chief Executive Officer) | Buy | 150,000 | 5.12 | 767,850 |
| 2024-05-14 | Kiernan Jane E | Buy | 19,356 | 5.17 | 99,993 |
| 2024-05-13 | Treace John T. (Chief Executive Officer) | Buy | 150,000 | 4.56 | 683,550 |
| 2024-05-13 | Mott Richard W | Buy | 36,802 | 4.38 | 161,082 |
| 2024-05-13 | Treace James T | Buy | 145,000 | 4.54 | 658,010 |
| 2024-05-10 | Treace John T. (Chief Executive Officer) | Buy | 150,000 | 4.58 | 686,850 |
| 2024-05-10 | Jain Deepti | Buy | 25,000 | 4.50 | 112,575 |
| 2024-05-10 | Mott Richard W | Buy | 83,198 | 4.57 | 379,882 |
| 2024-05-10 | Treace James T | Buy | 83,000 | 4.53 | 375,990 |
| 2024-05-10 | Bakewell John K | Buy | 130,000 | 4.57 | 594,620 |
| 2023-06-05 | Bays F Barry (Other) | Sale | 1,042,318 | 26.51 | 27,631,850 |
| 2023-06-02 | Bays F Barry (Other) | Sale | 48,503 | 26.51 | 1,285,814 |
| 2023-05-16 | Scanlan Sean F. (Chief Innovation Officer) | Sale | 25,000 | 25.44 | 635,975 |
| 2023-05-16 | Scanlan Sean F. (Chief Innovation Officer) | Option Ex | 25,000 | .10 | 2,500 |
| 2023-05-01 | Treace James T (Director) | Sale | 10,000 | 25.47 | 254,740 |
| 2023-04-28 | Treace James T (Director) | Sale | 40,000 | 25.01 | 1,000,280 |
| 2023-04-27 | Bays F Barry (Director) | Sale | 11,600 | 25.35 | 294,036 |
| 2023-04-26 | Bays F Barry (Director) | Sale | 16,204 | 25.55 | 414,012 |
| 2023-04-12 | Bays F Barry (Director) | Sale | 36,370 | 26.12 | 950,093 |
| 2023-04-11 | Bays F Barry (Director) | Sale | 49,790 | 26.78 | 1,333,326 |
| 2023-04-06 | Mott Richard W (Director) | Sale | 4,043 | 26.00 | 105,122 |
| 2023-04-04 | Mott Richard W (Director) | Sale | 15,756 | 26.00 | 409,671 |
| 2023-04-03 | Mott Richard W (Director) | Sale | 201 | 26.00 | 5,226 |
| 2023-03-31 | Mott Richard W (Director) | Sale | 95,000 | 25.36 | 2,409,010 |
| 2023-03-30 | Mott Richard W (Director) | Sale | 38,498 | 26.00 | 1,000,986 |
| 2023-03-30 | Treace James T (Director) | Sale | 50,000 | 25.86 | 1,293,150 |
| 2023-03-29 | Bays F Barry (Director) | Sale | 32,457 | 25.28 | 820,415 |
| 2023-03-28 | Bays F Barry (Director) | Sale | 26,241 | 25.02 | 656,654 |
| 2023-03-15 | Owens Daniel E. (Other) | Sale | 6,250 | 22.87 | 142,956 |
| 2023-03-15 | Owens Daniel E. (Other) | Option Ex | 6,250 | 7.03 | 43,925 |
| 2023-03-15 | Timbie Thomas E (Director) | Sale | 50,000 | 23.03 | 1,151,650 |
| 2023-03-14 | Bays F Barry (Director) | Sale | 9,400 | 23.25 | 218,531 |
| 2023-03-13 | Bays F Barry (Director) | Sale | 9,400 | 24.40 | 229,378 |
| 2023-03-09 | Elder Scot Michael (*See "Remarks") | Sale | 177 | 24.41 | 4,320 |
| 2023-03-09 | Berutti Aaron (Sr. VP, Sales) | Sale | 733 | 24.41 | 17,892 |
| 2023-03-09 | Owens Daniel E. (Other) | Sale | 411 | 24.41 | 10,032 |
| 2023-03-09 | Treace John T. (Chief Executive Offer) | Sale | 2,075 | 24.41 | 50,650 |
| 2023-03-09 | Scanlan Sean F. (Chief Innovation Officer) | Sale | 505 | 24.41 | 12,327 |
| 2023-03-09 | Hair Mark (Chief Financial Officer) | Sale | 1,040 | 24.41 | 25,386 |
| 2023-03-09 | Mott Richard W (Director) | Sale | 1,502 | 26.00 | 39,052 |
| 2023-03-08 | Mott Richard W (Director) | Sale | 45,000 | 23.25 | 1,046,250 |
| 2023-03-01 | Mott Richard W (Director) | Sale | 50,000 | 21.35 | 1,067,550 |
| 2023-03-01 | Treace James T (Director) | Sale | 12,684 | 21.36 | 270,930 |
| 2023-02-28 | Treace James T (Director) | Sale | 37,316 | 21.54 | 803,786 |
| 2023-02-22 | Bays F Barry (Director) | Sale | 9,400 | 21.97 | 206,536 |
| 2023-02-21 | Bays F Barry (Director) | Sale | 9,400 | 21.74 | 204,355 |
| 2023-02-15 | Scanlan Sean F. (Chief Innovation Officer) | Sale | 25,000 | 21.69 | 542,225 |
| 2023-02-15 | Scanlan Sean F. (Chief Innovation Officer) | Option Ex | 25,000 | .10 | 2,500 |
| 2023-02-15 | Timbie Thomas E (Director) | Sale | 50,000 | 21.71 | 1,085,350 |
| 2023-02-08 | Bays F Barry (Director) | Sale | 27,731 | 21.70 | 601,901 |
| 2023-02-07 | Bays F Barry (Director) | Sale | 8,800 | 23.00 | 202,364 |
| 2023-02-02 | Mott Richard W (Director) | Sale | 4,011 | 24.00 | 96,264 |
| 2023-01-31 | Treace James T (Director) | Sale | 11,929 | 23.19 | 276,633 |
| 2023-01-30 | Mott Richard W (Director) | Sale | 90,989 | 23.79 | 2,164,810 |
| 2023-01-30 | Treace James T (Director) | Sale | 38,071 | 23.74 | 903,881 |
| 2023-01-25 | Bays F Barry (Director) | Sale | 27,722 | 25.50 | 707,049 |
| 2023-01-24 | Bays F Barry (Director) | Sale | 25,921 | 26.03 | 674,749 |
| 2023-01-18 | Timbie Thomas E (Director) | Sale | 50,000 | 25.88 | 1,294,000 |
| 2023-01-17 | Mott Richard W (Director) | Sale | 11,014 | 26.00 | 286,375 |
| 2023-01-13 | Mott Richard W (Director) | Sale | 6,519 | 26.00 | 169,494 |
| 2023-01-12 | Scanlan Sean F. (Chief Innovation Officer) | Sale | 25,000 | 25.57 | 639,300 |
| 2023-01-12 | Scanlan Sean F. (Chief Innovation Officer) | Option Ex | 25,000 | .10 | 2,500 |
| 2023-01-12 | Mott Richard W (Director) | Sale | 42,467 | 26.00 | 1,104,184 |
| 2023-01-12 | Bays F Barry (Director) | Sale | 45,536 | 25.54 | 1,162,898 |
| 2023-01-11 | Bays F Barry (Director) | Sale | 9,719 | 24.32 | 236,366 |
| 2023-01-09 | Mott Richard W (Director) | Sale | 10,444 | 24.00 | 250,676 |
| 2023-01-05 | Mott Richard W (Director) | Sale | 9,556 | 24.00 | 229,363 |
| 2022-12-30 | Mott Richard W (Director) | Sale | 75,000 | 22.67 | 1,700,400 |
| 2022-12-20 | Bays F Barry (Director) | Sale | 9,414 | 23.24 | 218,781 |
| 2022-12-19 | Bays F Barry (Director) | Sale | 9,067 | 22.86 | 207,262 |
| 2022-12-12 | Treace James T (Director) | Sale | 25,000 | 24.18 | 604,575 |
| 2022-12-08 | Bays F Barry (Director) | Sale | 9,739 | 23.99 | 233,638 |
| 2022-12-07 | Bays F Barry (Director) | Sale | 9,061 | 23.97 | 217,192 |
| 2022-12-02 | Owens Daniel E. (Chief Human Resources Officer) | Sale | 5,625 | 25.00 | 140,625 |
| 2022-12-02 | Owens Daniel E. (Chief Human Resources Officer) | Option Ex | 5,625 | 12.01 | 67,578 |
| 2022-12-01 | Mott Richard W (Director) | Sale | 20,000 | 24.00 | 480,000 |
| 2022-11-30 | Mott Richard W (Director) | Sale | 75,000 | 21.90 | 1,642,800 |
| 2022-11-29 | Bays F Barry (Director) | Sale | 9,400 | 22.18 | 208,463 |
| 2022-11-28 | Bays F Barry (Director) | Sale | 9,400 | 22.09 | 207,664 |
| 2022-11-22 | Timbie Thomas E (Director) | Sale | 10,070 | 22.11 | 222,597 |
| 2022-11-21 | Berutti Aaron (Sr. VP, Sales) | Buy | 1,825 | 21.86 | 39,894 |
| 2022-11-21 | Treace John T. (Chief Executive Offer) | Buy | 15,000 | 21.83 | 327,405 |
| 2022-11-21 | Timbie Thomas E (Director) | Sale | 224 | 22.08 | 4,946 |
| 2022-11-18 | Timbie Thomas E (Director) | Sale | 39,706 | 23.06 | 915,501 |
| 2022-11-17 | Elder Scot Michael (*See "Remarks") | Buy | 3,736 | 21.48 | 80,230 |
| 2022-11-17 | Treace John T. (Chief Executive Offer) | Buy | 30,000 | 21.67 | 650,130 |
| 2022-11-16 | Timbie Thomas E (Director) | Sale | 50,000 | 20.14 | 1,006,900 |
| 2022-11-15 | Owens Daniel E. (Chief Human Resources Officer) | Sale | 6,250 | 20.38 | 127,368 |
| 2022-11-15 | Owens Daniel E. (Chief Human Resources Officer) | Option Ex | 6,250 | 7.03 | 43,925 |
| 2022-11-15 | Treace James T | Sale | 50,000 | 21.82 | 1,091,100 |
| 2022-11-14 | Scanlan Sean F. (SVP, Marketing) | Sale | 25,000 | 24.27 | 606,675 |
| 2022-11-14 | Scanlan Sean F. (SVP, Marketing) | Option Ex | 25,000 | .10 | 2,500 |
| 2022-10-31 | Mott Richard W (Director) | Sale | 95,000 | 23.57 | 2,238,960 |
| 2022-10-26 | Elder Scot Michael (*See "Remarks") | Sale | 613 | 23.46 | 14,380 |
| 2022-10-20 | Treace James T (Director) | Sale | 8,742 | 23.02 | 201,232 |
| 2022-10-19 | Treace James T (Director) | Sale | 41,258 | 22.98 | 948,232 |
| 2022-10-19 | Bays F Barry (Director) | Sale | 26,262 | 23.11 | 607,046 |
| 2022-10-18 | Bays F Barry (Director) | Sale | 25,428 | 24.02 | 610,780 |
| 2022-10-06 | Bays F Barry (Director) | Sale | 13,500 | 23.19 | 313,051 |
| 2022-10-05 | Bays F Barry (Director) | Sale | 16,274 | 22.57 | 367,271 |
| 2022-09-28 | Bays F Barry (Director) | Sale | 23,068 | 23.03 | 531,209 |
| 2022-09-27 | Bays F Barry (Director) | Sale | 14,424 | 22.36 | 322,491 |
| 2022-09-14 | Treace James T (Director) | Sale | 50,000 | 23.05 | 1,152,450 |
| 2022-09-14 | Bays F Barry (Director) | Sale | 48,657 | 23.56 | 1,146,358 |
| 2022-09-13 | Bays F Barry (Director) | Sale | 19,700 | 22.46 | 442,383 |
| 2022-09-02 | Owens Daniel E. (Chief Human Resources Officer) | Sale | 1,500 | 20.04 | 30,060 |
| 2022-09-02 | Owens Daniel E. (Chief Human Resources Officer) | Option Ex | 1,500 | 7.02 | 10,531 |
| 2022-09-01 | Owens Daniel E. (Chief Human Resources Officer) | Sale | 1,000 | 19.50 | 19,502 |
| 2022-09-01 | Owens Daniel E. (Chief Human Resources Officer) | Option Ex | 1,000 | 7.03 | 7,028 |
| 2022-09-01 | Treace John T. (Chief Executive Offer) | Buy | 10,000 | 19.80 | 198,030 |
| 2022-08-30 | Bays F Barry (Director) | Sale | 3,800 | 20.15 | 76,570 |
| 2022-08-29 | Bays F Barry (Director) | Sale | 8,064 | 20.10 | 162,070 |
| 2022-08-26 | Treace John T. (Chief Executive Offer) | Buy | 21,491 | 20.95 | 450,343 |
| 2022-08-24 | Treace John T. (Chief Executive Offer) | Buy | 509 | 18.92 | 9,631 |
| 2022-08-23 | Treace John T. (Chief Executive Offer) | Buy | 28,000 | 18.72 | 524,132 |
| 2022-08-18 | Treace James T (Director) | Sale | 34,046 | 19.09 | 649,938 |
| 2022-08-17 | Treace James T (Director) | Sale | 15,954 | 19.54 | 311,741 |
| 2022-08-16 | Timbie Thomas E (Director) | Sale | 50,000 | 19.91 | 995,500 |
| 2022-08-15 | Owens Daniel E. (Chief Human Resources Officer) | Sale | 1,500 | 20.00 | 30,000 |
| 2022-08-15 | Owens Daniel E. (Chief Human Resources Officer) | Option Ex | 1,500 | 7.03 | 10,542 |
| 2022-08-05 | Timbie Thomas E (Director) | Sale | 4,904 | 19.04 | 93,372 |
| 2022-08-04 | Timbie Thomas E (Director) | Sale | 48,217 | 18.56 | 894,714 |
| 2022-08-03 | Timbie Thomas E (Director) | Sale | 96,879 | 18.85 | 1,825,878 |
| 2022-08-01 | Owens Daniel E. (Chief Human Resources Officer) | Sale | 1,000 | 16.89 | 16,890 |
| 2022-08-01 | Owens Daniel E. (Chief Human Resources Officer) | Option Ex | 1,000 | 7.03 | 7,028 |
| 2022-07-19 | Treace James T | Sale | 20,239 | 16.11 | 326,090 |
| 2022-07-18 | Treace James T | Sale | 13,961 | 16.26 | 226,963 |
| 2022-07-15 | Treace James T | Sale | 8,456 | 16.18 | 136,826 |
| 2022-07-14 | Treace James T | Sale | 2,800 | 16.03 | 44,892 |
| 2022-07-13 | Treace James T | Sale | 4,544 | 16.13 | 73,285 |
| 2022-06-17 | Treace James T | Sale | 29,191 | 13.73 | 400,909 |
| 2022-06-16 | Treace James T | Sale | 20,809 | 13.58 | 282,565 |
| 2022-06-01 | Owens Daniel E. (Chief HR Officer) | Sale | 1,000 | 16.67 | 16,670 |
| 2022-06-01 | Owens Daniel E. (Chief HR Officer) | Option Ex | 1,000 | 7.03 | 7,028 |
| 2022-05-26 | Treace James T | Sale | 19,687 | 15.77 | 310,542 |
| 2022-05-25 | Treace James T | Sale | 30,313 | 15.35 | 465,334 |
| 2022-05-18 | Hair Mark (Chief Financial Officer) | Buy | 6,200 | 15.80 | 97,960 |
| 2022-05-09 | Owens Daniel E. (Chief HR Officer) | Sale | 1,000 | 15.96 | 15,960 |
| 2022-05-09 | Owens Daniel E. (Chief HR Officer) | Option Ex | 1,000 | 7.03 | 7,028 |
| 2022-05-09 | Treace John R | Sale | 75,000 | 14.67 | 1,100,325 |
| 2022-03-10 | Treace James T | Sale | 2 | 19.20 | 38 |
| 2022-03-08 | Lubben Terry W. (SVP, Operations) | Buy | 2,500 | 18.62 | 46,550 |
| 2022-03-02 | Scanlan Sean F. (SVP, Marketing) | Sale | 25,000 | 20.82 | 520,550 |
| 2022-03-02 | Scanlan Sean F. (SVP, Marketing) | Option Ex | 25,000 | 1.05 | 26,250 |
| 2022-02-09 | Scanlan Sean F. (SVP, Marketing) | Sale | 3,873 | 20.16 | 78,083 |
| 2022-02-09 | Scanlan Sean F. (SVP, Marketing) | Option Ex | 3,873 | 1.05 | 4,066 |
| 2022-02-08 | Scanlan Sean F. (SVP, Marketing) | Sale | 21,127 | 20.02 | 422,899 |
| 2022-02-08 | Scanlan Sean F. (SVP, Marketing) | Option Ex | 21,127 | 1.05 | 22,183 |
| 2022-01-19 | Treace James T | Sale | 32,063 | 18.99 | 608,972 |
| 2022-01-18 | Treace James T | Sale | 42,937 | 19.68 | 845,043 |
| 2022-01-11 | Scanlan Sean F. (SVP, Marketing) | Sale | 8,838 | 20.12 | 177,847 |
| 2022-01-11 | Scanlan Sean F. (SVP, Marketing) | Option Ex | 8,838 | 1.31 | 11,577 |
| 2022-01-10 | Scanlan Sean F. (SVP, Marketing) | Sale | 38,862 | 20.16 | 783,535 |
| 2022-01-10 | Scanlan Sean F. (SVP, Marketing) | Option Ex | 38,862 | 1.57 | 61,013 |
| 2022-01-05 | Scanlan Sean F. (SVP, Marketing) | Sale | 800 | 20.02 | 16,018 |
| 2022-01-05 | Scanlan Sean F. (SVP, Marketing) | Option Ex | 800 | 1.57 | 1,256 |
| 2022-01-04 | Scanlan Sean F. (SVP, Marketing) | Sale | 500 | 20.00 | 10,000 |
| 2022-01-04 | Scanlan Sean F. (SVP, Marketing) | Option Ex | 500 | 1.57 | 785 |
| 2022-01-03 | Scanlan Sean F. (SVP, Marketing) | Sale | 1,000 | 20.02 | 20,021 |
| 2022-01-03 | Scanlan Sean F. (SVP, Marketing) | Option Ex | 1,000 | 1.57 | 1,570 |
| 2021-12-29 | Treace John T. (Chief Executive Officer) | Sale | 3,075 | 17.01 | 52,314 |
| 2021-12-28 | Treace John T. (Chief Executive Officer) | Sale | 19,760 | 16.99 | 335,801 |
| 2021-12-28 | Treace James T | Sale | 1,563 | 16.88 | 26,386 |
| 2021-12-27 | Treace John T. (Chief Executive Officer) | Sale | 17,165 | 17.44 | 299,374 |
| 2021-12-27 | Treace James T | Sale | 6,437 | 17.46 | 112,377 |
| 2021-12-23 | Treace John T. (Chief Executive Officer) | Sale | 22,795 | 16.96 | 386,534 |
| 2021-12-23 | Treace James T | Sale | 12,610 | 16.90 | 213,159 |
| 2021-12-22 | Treace John T. (Chief Executive Officer) | Sale | 41,710 | 16.29 | 679,372 |
| 2021-12-22 | Treace James T | Sale | 23,390 | 16.28 | 380,695 |
| 2021-12-21 | Treace John T. (Chief Executive Officer) | Sale | 37,584 | 16.23 | 609,875 |
| 2021-12-21 | Treace James T | Sale | 14,881 | 16.24 | 241,682 |
| 2021-12-20 | Treace John T. (Chief Executive Officer) | Sale | 22,911 | 16.02 | 367,080 |
| 2021-12-20 | Treace James T | Sale | 16,119 | 15.99 | 257,791 |
| 2021-12-15 | Treace James T | Sale | 75,000 | 16.46 | 1,234,575 |
| 2021-11-24 | Treace John T. (Chief Executive Officer) | Sale | 56,000 | 17.83 | 998,536 |
| 2021-11-24 | Treace James T | Sale | 17,000 | 17.83 | 303,042 |
| 2021-11-23 | Treace John T. (Chief Executive Officer) | Sale | 56,000 | 17.69 | 990,472 |
| 2021-11-23 | Treace James T | Sale | 17,000 | 17.89 | 304,130 |
| 2021-11-22 | Treace John T. (Chief Executive Officer) | Sale | 53,000 | 18.73 | 992,425 |
| 2021-11-22 | Treace James T | Sale | 16,000 | 18.95 | 303,200 |
| 2021-11-17 | Treace James T | Sale | 25,000 | 20.33 | 508,249 |
| 2021-11-16 | Treace James T | Sale | 25,000 | 20.86 | 521,500 |
| 2021-11-15 | Treace James T | Sale | 25,000 | 20.91 | 522,750 |
| 2021-11-10 | Scanlan Sean F. (SVP, Marketing) | Sale | 25,000 | 21.86 | 546,550 |
| 2021-11-10 | Scanlan Sean F. (SVP, Marketing) | Option Ex | 25,000 | 1.57 | 39,250 |
| 2021-10-22 | Treace John T. (Chief Executive Officer) | Sale | 58,089 | 20.95 | 1,216,906 |
| 2021-10-21 | Treace John T. (Chief Executive Officer) | Sale | 76,084 | 22.25 | 1,692,716 |
| 2021-10-20 | Treace John T. (Chief Executive Officer) | Sale | 30,827 | 25.08 | 773,048 |
| 2021-10-20 | Timbie Thomas E | Sale | 11,171 | 25.18 | 281,241 |
| 2021-10-06 | Ferguson Joe W. (SVP, Research & Development) | Option Ex | 308,641 | .10 | 30,864 |
| 2021-04-27 | Treace John T. (Chief Executive Officer) | Sale | 5,253,805 | 17.00 | 89,314,685 |
| 2021-04-27 | Frias Jaime A. (See Remarks) | Sale | 329,230 | 17.00 | 5,596,910 |
| 2021-04-27 | Hair Mark (Chief Financial Officer) | Buy | 13,600 | 17.00 | 231,200 |
Insider trading activities including stock purchases, stock sales, and option exercises of TMCI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Treace Medical Concepts, Inc. (symbol TMCI, CIK number 1630627) see the Securities and Exchange Commission (SEC) website.